Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted TherapiesNils Kroeger, Daniel Yick Chin Heng, Haoran Li et al.|Clinical Genitourinary Cancer|2018Cited by 15
The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model as a prognostic tool in metastatic renal cell carcinoma (mRCC) patients previously treated with first-line targeted therapy (TT).Jenny J. Ko, Toni K. Choueiri, Jennifer J. Knox et al.|Journal of Clinical Oncology|2014Cited by 10
Characterizing sites of metastatic involvement in metastatic clear-cell, papillary, and chromophobe renal cell carcinoma.Shaan Dudani, Daniel Yick Chin Heng, Guillermo de Velasco et al.|Journal of Clinical Oncology|2020Cited by 2
Impact of bone and liver metastases (BM, LM) in patients with metastatic renal cell carcinoma (mRCC) treated with molecularly targeted agents (MTAs): Results from the International mRCC Database Consortium (IMDC).Rana R. McKay, Toni K. Choueiri, Nils Kroeger et al.|Journal of Clinical Oncology|2013Cited by 2
First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An updated analysis from the International mRCC Database Consortium (IMDC).Lauren C. Harshman, Toni K. Choueiri, Nils Kroeger et al.|Journal of Clinical Oncology|2013Cited by 2